Cargando…

Serum Cardiotrophin-1 Concentration Is Negatively Associated with Controlled Attenuation Parameters in Subjects with Non-Alcoholic Fatty Liver Disease

Background: Since non-alcoholic fatty liver disease (NAFLD) is highly associated with obesity, cardiovascular disease, and diabetes, biomarkers for the diagnosis of NAFLD have become an important issue. Although cardiotrophin-1 (CT-1) has a protective effect on the liver in NAFLD animal models, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yi-Chun, Wu, Juei-Seng, Chou, Hsuan-Wen, Kuo, Hsin-Yu, Lee, Chun-Te, Wu, Hung-Tsung, Li, Chung-Hao, Ou, Horng-Yih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095180/ https://www.ncbi.nlm.nih.gov/pubmed/37048824 http://dx.doi.org/10.3390/jcm12072741

Ejemplares similares

Cardiotrophin-1 is inversely associated with obesity in non-diabetic individuals
por: Hung, Hao-Chang, et al.
Publicado: (2015)

The Serum Concentrations of Hedgehog-Interacting Protein, a Novel Biomarker, Were Decreased in Overweight or Obese Subjects
por: Chou, Hsuan-Wen, et al.
Publicado: (2021)

Role of cardiotrophin-1 in obesity and insulin resistance
por: Moreno-Aliaga, María J., et al.
Publicado: (2012)

Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression
por: Miteva, Kapka, et al.
Publicado: (2020)

Increased Expression of Cardiotrophin-1 in Cardiomyopathy Patients
por: Sharif, S, et al.
Publicado: (2021)

Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels
por: Lin, Chun-Chung, et al.
Publicado: (2019)

Coral Hydrate, a Novel Antioxidant, Improves Alcohol Intoxication in Mice
por: Wu, Hung-Tsung, et al.
Publicado: (2022)

Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity
por: Asrih, Mohamed, et al.
Publicado: (2013)

Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart
por: Abdul-Ghani, Mohammad, et al.
Publicado: (2017)

The Expression of Adipose Tissue-Derived Cardiotrophin-1 in Humans with Obesity
por: Stephens, Jacqueline, et al.
Publicado: (2019)

Calsarcin-2 May Play a Compensatory Role in the Development of Obese Sarcopenia
por: Liang, Yu-Cheng, et al.
Publicado: (2023)

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011)

Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure
por: Celik, Atac, et al.
Publicado: (2012)

Hypertension in adult Fabry’s disease: is cardiotrophin-1 a diagnostic biomarker?
por: Marazzi, Monica Gioia, et al.
Publicado: (2014)

Cardiotrophin-1: a new player in energy metabolism with potential therapeutic application
por: Bustos, Matilde, et al.
Publicado: (2011)

Cardiotrophin-1 Induces Matrix Metalloproteinase-1 in Human Aortic Endothelial Cells
por: Tokito, Akinori, et al.
Publicado: (2013)

A quantitative detection of Cardiotrophin‐1 in chronic heart failure by chemiluminescence immunoassay
por: Ping, Ying, et al.
Publicado: (2021)

Characteristics of sarcopenia subjects in arterial pulse spectrum analysis
por: Ou Young, Te, et al.
Publicado: (2022)

Immunomodulatory effects of cardiotrophin-1 on in vitro cytokine production of monocytes & CD4(+) T-lymphocytes
por: Fritzenwanger, Michael, et al.
Publicado: (2012)

Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
por: Hogas, Simona, et al.
Publicado: (2016)

Preventive Effect of Cardiotrophin-1 Administration before DSS-Induced Ulcerative Colitis in Mice
por: Sánchez-Garrido, Ana I., et al.
Publicado: (2019)

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
por: Chen, Hsuan-Wei, et al.
Publicado: (2021)

Compensatory Increase of Serum Hepassocin Protects Hyperthyroidism-Induced Hepatic Dysfunction
por: Wang, Chih-Chen, et al.
Publicado: (2023)

Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
por: Escoté, Xavier, et al.
Publicado: (2017)

Cardiotrophin-1 and leptin as cardiovascular risk markers in male patients with obstructive sleep apnea syndrome
por: Cakir, Isil, et al.
Publicado: (2018)

Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function
por: Pasquin, Sarah, et al.
Publicado: (2019)

Enigmatic Ectopic Fat: Prevalence of Nonalcoholic Fatty Pancreas Disease and Its Associated Factors in a Chinese Population
por: Wang, Chih‐Yuan, et al.
Publicado: (2014)

Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
por: Wu, Juei-Seng, et al.
Publicado: (2023)

Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning
por: Iñiguez, Maria, et al.
Publicado: (2006)

Cardiotrophin-1 Induces Tumor Necrosis Factor α Synthesis in Human Peripheral Blood Mononuclear Cells
por: Fritzenwanger, Michael, et al.
Publicado: (2009)

Common Genetic Variation in the Human CTF1 Locus, Encoding Cardiotrophin-1, Determines Insulin Sensitivity
por: Lutz, Stefan Z., et al.
Publicado: (2014)

Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk
por: Gamella-Pozuelo, Luis, et al.
Publicado: (2015)

Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2013)

Functional Improvement of Human Cardiotrophin 1 Produced in Tobacco Chloroplasts by Co-Expression with Plastid Thioredoxin m
por: Ancín, María, et al.
Publicado: (2020)

Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin
por: Chou, Hsuan-Wen, et al.
Publicado: (2022)

Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article
por: Lin, Ying-Chun, et al.
Publicado: (2021)

Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study
por: Yen, Yi-Hao, et al.
Publicado: (2017)

Elevated Hedgehog-Interacting Protein Levels in Subjects with Prediabetes and Type 2 Diabetes
por: Lin, An-Chi, et al.
Publicado: (2019)

Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanism
por: Bustos, Matilde, et al.
Publicado: (2012)

Effect of human very low-density lipoproteins on cardiotrophin-like cytokine factor 1 (CLCF1) activity
por: Pasquin, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fkqgdaqsi722e1ev769jpkv8lb